Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Saint Louis University
mi
from
St. Louis, MO
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Saint Louis University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
St. Patrick Hospital
mi
from
Missoula, MT
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
St. Patrick Hospital
mi
from
Missoula, MT
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Nebraska Medical Center
mi
from
Omaha, NE
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Nebraska Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Robert Wood Johnson University Hospital
mi
from
New Brunswick, NJ
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Robert Wood Johnson University Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Albany Medical Center Hospital
mi
from
Albany, NY
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Albany Medical Center Hospital
mi
from
Albany, NY
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Westchester Medical Center
mi
from
Valhalla, NY
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Westchester Medical Center
mi
from
Valhalla, NY
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Mission Hospital, Inc
mi
from
Asheville, NC
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Mission Hospital, Inc
mi
from
Asheville, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Carolinas Medical Center
mi
from
Charlotte, NC
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Summa Health System
mi
from
Akron, OH
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Summa Health System
mi
from
Akron, OH
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
MetroHealth Med Ctr
mi
from
Cleveland, OH
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Miami Valley Hospital
mi
from
Dayton, OH
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Miami Valley Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Toledo Hospital
mi
from
Toledo, OH
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Toledo Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
St Elizabeth Health Center
mi
from
Youngstown, OH
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
St Elizabeth Health Center
mi
from
Youngstown, OH
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
OU Medical Center
mi
from
Oklahoma City, OK
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
OU Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Legacy Emanuel Hospital and Health Center
mi
from
Portland, OR
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Legacy Emanuel Hospital and Health Center
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Allegheny General Hospital
mi
from
Pittsburgh, PA
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Reading Hospital & Medical Center
mi
from
West Reading, PA
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Reading Hospital & Medical Center
mi
from
West Reading, PA
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Medical University of South Carolina
mi
from
Charleston, SC
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
University of South Carolina School of Medicine
mi
from
Columbia, SC
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
University of South Carolina School of Medicine
mi
from
Columbia, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Johnson City Medical Center
mi
from
Johnson City, TN
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Johnson City Medical Center
mi
from
Johnson City, TN
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Vanderbilt University Medical Center
mi
from
Nashville, TN
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Texas Tech University Health Sciences Center
mi
from
El Paso, TX
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Texas Tech University Health Sciences Center
mi
from
El Paso, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
University of Virginia Health System
mi
from
Charlottesville, VA
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
Marshall University Joan C. Edwards School of Medicine
mi
from
Huntington, WV
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
Marshall University Joan C. Edwards School of Medicine
mi
from
Huntington, WV
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
West Virginia University Hospital
mi
from
Morgantown, WV
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
West Virginia University Hospital
mi
from
Morgantown, WV
Click here to add this to my saved trials
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated:  3/8/2013
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Investigate the Efficacy and Safety of Progesterone in Patients With Severe Traumatic Brain Injury
Status: Enrolling
Updated: 3/8/2013
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Dalfampridine and Gait in Spinocerebellar Ataxias
Therapeutic Effect of Dalfampridine on Gait Incoordination in Spinocerebellar Ataxias- A Randomized, Double-blinded, Placebo-controlled, Crossover Clinical Trial
Status: Enrolling
Updated:  3/13/2013
University of Florida
mi
from
Gainesville, FL
Dalfampridine and Gait in Spinocerebellar Ataxias
Therapeutic Effect of Dalfampridine on Gait Incoordination in Spinocerebellar Ataxias- A Randomized, Double-blinded, Placebo-controlled, Crossover Clinical Trial
Status: Enrolling
Updated: 3/13/2013
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated:  3/15/2013
Hartford Hospital
mi
from
Hartford, CT
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated: 3/15/2013
Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated:  3/15/2013
University of Maryland R Cowley Shock Trauma Center
mi
from
Baltimore, MD
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated: 3/15/2013
University of Maryland R Cowley Shock Trauma Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated:  3/15/2013
Sinai Hospital
mi
from
Baltimore, MD
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated: 3/15/2013
Sinai Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated:  3/15/2013
Wayne State University/Detroit Receiving Hospital
mi
from
Detroit, MI
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated: 3/15/2013
Wayne State University/Detroit Receiving Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated:  3/15/2013
Wayne State University - Sinai Grace Hospital
mi
from
Detroit, MI
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated: 3/15/2013
Wayne State University - Sinai Grace Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated:  3/15/2013
Washington University/Barnes Jewish Hospital
mi
from
St. Louis, MO
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated: 3/15/2013
Washington University/Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated:  3/15/2013
Univ of Rochester Medical Center
mi
from
Rochester, NY
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated: 3/15/2013
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated:  3/15/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated: 3/15/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated:  3/15/2013
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated: 3/15/2013
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated:  3/15/2013
University of Virginia Medical Center
mi
from
Charlottesville, VA
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated: 3/15/2013
University of Virginia Medical Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated:  3/15/2013
Inova Health System
mi
from
Falls Church, VA
Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology
Assessment of Head Injury in the Emergency Department: Clinical Validation of the BrainScope® Ahead™ Technology
Status: Enrolling
Updated: 3/15/2013
Inova Health System
mi
from
Falls Church, VA
Click here to add this to my saved trials
Remote Ischemic Preconditioning in Subarachnoid Hemorrhage
Prophylactic Remote Ischemic Preconditioning for Cerebral Vasospasm Following Subarachnoid Hemorrhage
Status: Enrolling
Updated:  3/24/2013
UCLA Ronald Reagan Medical Center
mi
from
Los Angeles, CA
Remote Ischemic Preconditioning in Subarachnoid Hemorrhage
Prophylactic Remote Ischemic Preconditioning for Cerebral Vasospasm Following Subarachnoid Hemorrhage
Status: Enrolling
Updated: 3/24/2013
UCLA Ronald Reagan Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  3/24/2013
Forest Investigative Site 001
mi
from
Dothan, AL
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 3/24/2013
Forest Investigative Site 001
mi
from
Dothan, AL
Click here to add this to my saved trials
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  3/24/2013
Forest Investigative Site
mi
from
Phoenix, AZ
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 3/24/2013
Forest Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  3/24/2013
Forest Investigative Site 055
mi
from
Tucson, AZ
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 3/24/2013
Forest Investigative Site 055
mi
from
Tucson, AZ
Click here to add this to my saved trials
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  3/24/2013
Forest Investigative Site 077
mi
from
Little Rock, AR
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 3/24/2013
Forest Investigative Site 077
mi
from
Little Rock, AR
Click here to add this to my saved trials
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  3/24/2013
Forest Investigative Site 054
mi
from
Glendale, CA
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 3/24/2013
Forest Investigative Site 054
mi
from
Glendale, CA
Click here to add this to my saved trials
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  3/24/2013
Forest Investigative Site 109
mi
from
Imperial, CA
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 3/24/2013
Forest Investigative Site 109
mi
from
Imperial, CA
Click here to add this to my saved trials
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  3/24/2013
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 3/24/2013
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  3/24/2013
Forest Investigative Site 17
mi
from
Los Angeles, CA
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 3/24/2013
Forest Investigative Site 17
mi
from
Los Angeles, CA
Click here to add this to my saved trials